相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel EBV LMP1 C-terminal domain binding affibody molecules as potential agents for in vivo molecular imaging diagnosis of nasopharyngeal carcinoma
Saidu Kamara et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)
A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3
Alexander Rau et al.
MABS (2021)
Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells
Jinshun Zhu et al.
CELL DEATH & DISEASE (2020)
Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3
Alexander Rau et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Bispecific affibody molecule targeting HPV16 and HPV18E7 oncoproteins for enhanced molecular imaging of cervical cancer
Shanli Zhu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis
Yi Li et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Evaluation of the Therapeutic Potential of a HER3-Binding Affibody Construct TAM-HER3 in Comparison with a Monoclonal Antibody, Seribantumab
Anna Orlova et al.
MOLECULAR PHARMACEUTICS (2018)
A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer
Pengfei Jiang et al.
THERANOSTICS (2018)
TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies
Mahiuddin Ahmed et al.
JCI INSIGHT (2018)
Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions
Ana Luiza Ribeiro de Souza et al.
MOLECULAR IMAGING AND BIOLOGY (2017)
Affibody Molecules in Biotechnological and Medical Applications
Stefan Stahl et al.
TRENDS IN BIOTECHNOLOGY (2017)
A small-molecule dye for NIR-II imaging
Alexander L. Antaris et al.
NATURE MATERIALS (2016)
Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator
Ken G. Andersson et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Generation of affibody molecules specific for HPV16 E7 recognition
Xiangyang Xue et al.
ONCOTARGET (2016)
Induction of protective and therapeutic anti-cancer immunity by using bispecific anti-idiotype antibody G22-I50 for nasopharyngeal carcinoma
Jia-Jia Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia
Jingjing Wu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Alternative molecular formats and therapeutic applications for bispecific antibodies
Christoph Spiess et al.
MOLECULAR IMMUNOLOGY (2015)
Affibody-mediated PET imaging of HER3 expression in malignant tumours
Maria Rosestedt et al.
SCIENTIFIC REPORTS (2015)
MM-141, an IGF-IR- and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
Jonathan B. Fitzgerald et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation
Shyhmin Huang et al.
CANCER RESEARCH (2013)
Plasma Half-life Extension of Small Recombinant Antibodies by Fusion to Immunoglobulin-binding Domains
Meike Hutt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
Charlotte F. McDonagh et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)
Christopher W. Dawson et al.
SEMINARS IN CANCER BIOLOGY (2012)
Affibody-based nanoprobes for HER2-expressing cell and tumor imaging
Jinhao Gao et al.
BIOMATERIALS (2011)
A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies
Gabriele Schaefer et al.
CANCER CELL (2011)
The Development of Peptide-Based Tools for the Analysis of Angiogenesis
Anna Fedorova et al.
CHEMISTRY & BIOLOGY (2011)
Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules
Nina Kronqvist et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2011)
Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
J. Lofblom et al.
FEBS LETTERS (2010)
Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule
Mikaela Friedman et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2009)
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Engineered protein scaffolds as next-generation antibody therapeutics
Michaela Gebauer et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
68Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging
Zhaofei Liu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
HPV & head and neck cancer: a descriptive update
Peter K. C. Goon et al.
HEAD & NECK ONCOLOGY (2009)
The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer
Mei-Fong Pang et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2009)
Bifunctional enhancement of a β-glucanase-xylanase fusion enzyme by optimization of peptide linkers
Ping Lu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2008)
Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line
Lina Ekerljung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
HER-2-Targeted Nanoparticle-Affibody Bioconjugates for Cancer Therapy
Frank Alexis et al.
CHEMMEDCHEM (2008)
Vertical VEGF targeting: A combination of ligand blockade with receptor tyrosine kinase inhibition
Alexandre Bozec et al.
EUROPEAN JOURNAL OF CANCER (2008)
Tumor Imaging using a picomolar affinity HER2 binding affibody molecule
A Orlova et al.
CANCER RESEARCH (2006)
Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells
S Offner et al.
MOLECULAR IMMUNOLOGY (2006)
Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K
BA Mainou et al.
ONCOGENE (2005)
Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer
CH Yeon et al.
INVESTIGATIONAL NEW DRUGS (2005)
Antibody engineering: facing new challenges in cancer therapy
L Sanz et al.
ACTA PHARMACOLOGICA SINICA (2005)
Chemical synthesis of triple-labelled three-helix bundle binding proteins for specific fluorescent detection of unlabelled protein
T Engfeldt et al.
CHEMBIOCHEM (2005)
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
ATC Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
SQ Li et al.
CANCER CELL (2005)
Complement activation determines the therapeutic activity of rituximab in vivo
N Di Gaetano et al.
JOURNAL OF IMMUNOLOGY (2003)
Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody
T Dreier et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Anti-idiotypic protein domains selected from protein A-based affibody libraries
M Eklund et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2002)
分享论文
